Cargando…
Lysosomal accumulation of anticancer drugs triggers lysosomal exocytosis
We have recently shown that hydrophobic weak base anticancer drugs are highly sequestered in acidic lysosomes, inducing TFEB-mediated lysosomal biogenesis and markedly increased lysosome numbers per cell. This enhanced lysosomal sequestration of chemotherapeutics, away from their intracellular targe...
Autores principales: | Zhitomirsky, Benny, Assaraf, Yehuda G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5542171/ https://www.ncbi.nlm.nih.gov/pubmed/28187461 http://dx.doi.org/10.18632/oncotarget.15155 |
Ejemplares similares
-
Lysosomal sequestration of hydrophobic weak base chemotherapeutics triggers lysosomal biogenesis and lysosome-dependent cancer multidrug resistance
por: Zhitomirsky, Benny, et al.
Publicado: (2014) -
Correction: Lysosomal sequestration of hydrophobic weak base chemotherapeutics triggers lysosomal biogenesis and lysosome-dependent cancer multidrug resistance
por: Zhitomirsky, Benny, et al.
Publicado: (2022) -
Lysosomotropic drugs activate TFEB via lysosomal membrane fluidization and consequent inhibition of mTORC1 activity
por: Zhitomirsky, Benny, et al.
Publicado: (2018) -
LysoTracker and MitoTracker Red are transport substrates of P‐glycoprotein: implications for anticancer drug design evading multidrug resistance
por: Zhitomirsky, Benny, et al.
Publicado: (2018) -
Cyclodextrin Induces Calcium-Dependent Lysosomal Exocytosis
por: Chen, Fannie W., et al.
Publicado: (2010)